What amount sold does Canton Strategic Holdings, Inc. report in Form D filings?

The latest linked filings report $9.6M sold across 5 identified offering(s). 0 unlinked amendment(s) are excluded; 0 offering(s) have no reported amount sold. This is not verified lifetime funding or money raised during a specific period.

When was Canton Strategic Holdings, Inc.'s most recent SEC filing?

Canton Strategic Holdings, Inc.'s most recent Form D filing was on 2026-04-15.

How many investors does Canton Strategic Holdings, Inc. have?

The most recent Form D filing lists 6 investor(s).

What type of securities does Canton Strategic Holdings, Inc. offer?

Canton Strategic Holdings, Inc.'s SEC Form D filings indicate equity offerings.

Canton Strategic Holdings, Inc.

CIK: 0001861657·Biotechnology·RED BANK, NJ·Corporation

Reported Sold

$9,569,163

Total Filings

Identified Offerings

Last Filed

Apr 15, 2026

Employees

—

Reported sold uses the latest linked filing for each identified offering; it is not verified lifetime funding. SPV filings are shown separately.

About

Company in Biotechnology industry

SEC EDGAR

Offering filing timeline

Apr 15, 2026Form D — New notice

Reported sold: $1,740,000 · Target: $1,740,000

Rule 506(b)·13 investors

Apr 15, 2026Form D — New notice

Reported sold: $1,225,003 · Target: $1,225,003

Rule 506(b)·6 investors

Jul 7, 2025Form D — New notice

Reported sold: $2,500,000 · Target: $2,500,000

Rule 506(b)·30 investors

Dec 17, 2024Form D — New notice

Reported sold: $2,020,000 · Target: $2,020,000

Rule 506(b)·7 investors

Jun 28, 2024Form D — New notice

Reported sold: $2,084,160 · Target: $2,084,160

Rule 506(b)·5 investors

Fundraising Profile

Exemptions

Rule 506(b)

Investors in latest filing

Revenue Range

Decline to Disclose

Reported commissions across identified offerings

$628,800

Amendment Rate

Latest reported sold across 5 identified offerings

$9,569,163

Uses the latest linked filing for each offering. This is not a measure of money raised in the last year or verified lifetime funding.

Key People

Randy Milby

Related Person

Appears on 2 filings

Thomas Hess

Related Person

Appears on 2 filings

Sireesh Appajosyula

Related Person

Appears on 2 filings

Leonard Mazur

Related Person

Appears on 2 filings

Lynne A/ Bui

Related Person

Appears on 2 filings

Kelly Anderson

Related Person

Appears on 2 filings

Sanam Parikh

Related Person

Appears on 1 filing

Sireesh Appajosyula

Related Person

Appears on 1 filing

Filing History

Date	Type	Offering target	Reported sold	Investors
Apr 15, 2026	New	$1,740,000	$1,740,000	13
Apr 15, 2026	New	$1,225,003	$1,225,003	6
Jul 7, 2025	New	$2,500,000	$2,500,000	30
Dec 17, 2024	New	$2,020,000	$2,020,000	7
Jun 28, 2024	New	$2,084,160	$2,084,160	5

Filing History

Amendment insights

Loading amendment history…

Comparable issuers

Matched on reported industry and issuer type, then ranked by business location, offering target, and recency. These are filing comparables, not verified business competitors.

Bullseye Biodevices, Inc.

Biotechnology

Offering target: $1,299,999

Filed Aug 7, 2026